Cooper Companies - COO Stock Forecast, Price & News

9 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Cooper Companies in the last year. There are currently 2 hold ratings and 7 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" COO shares.
View COO analyst ratings or view top-rated stocks.

9 analysts have issued 12 month target prices for Cooper Companies' stock. Their COO share price forecasts range from $295.00 to $460.00. On average, they anticipate the company's stock price to reach $382.60 in the next twelve months. This suggests a possible upside of 7.3% from the stock's current price.
View analysts price targets for COO or view top-rated stocks among Wall Street analysts.

Cooper Companies' stock was trading at $330.67 at the beginning of the year. Since then, COO stock has increased by 7.8% and is now trading at $356.59.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, June 1st 2023.
View our COO earnings forecast.

The Cooper Companies, Inc. (NYSE:COO) released its earnings results on Thursday, March, 2nd. The medical device company reported $2.90 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $2.66 by $0.24. The medical device company earned $858.50 million during the quarter, compared to analyst estimates of $834.90 million. Cooper Companies had a net margin of 11.10% and a trailing twelve-month return on equity of 8.39%. The business's quarterly revenue was up 9.1% on a year-over-year basis. During the same period in the previous year, the business posted $3.24 EPS.
Read the conference call transcript.

Cooper Companies declared a Semi-Annual dividend on Wednesday, December 14th. Shareholders of record on Monday, January 23rd will be given a dividend of $0.03 per share on Friday, February 10th. The ex-dividend date of this dividend is Friday, January 20th.
Read our dividend analysis for COO.

ETFs with the largest weight of Cooper Companies (NYSE:COO) stock in their portfolio include Motley Fool Mid-Cap Growth ETF (TMFM), BNY Mellon Sustainable US Equity ETF (BKUS), Goldman Sachs Future Health Care Equity ETF (GDOC), First Trust Indxx Medical Devices ETF (MDEV), Nuveen ESG Mid-Cap Growth ETF (NUMG), BlackRock Future Health ETF (BMED), Putnam Sustainable Future ETF (PFUT) and Invesco S&P 500 Equal Weight Health Care ETF (RYH).

Cooper Companies (NYSE:COO) pays an annual dividend of $0.06 per share and currently has a dividend yield of 0.02%. The dividend payout ratio is 0.79%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, COO will have a dividend payout ratio of 0.42% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for COO.

Cooper Companies issued an update on its FY 2023 earnings guidance on Thursday, March, 2nd. The company provided earnings per share (EPS) guidance of $12.60-$12.90 for the period, compared to the consensus earnings per share estimate of $12.52. The company issued revenue guidance of $3.50 billion-$3.55 billion, compared to the consensus revenue estimate of $3.50 billion.

8 employees have rated Cooper Companies Chief Executive Officer Robert S. Weiss on Glassdoor.com. Robert S. Weiss has an approval rating of 80% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Cooper Companies investors own include Boeing (BA), AbbVie (ABBV), NVIDIA (NVDA), Netflix (NFLX), Johnson & Johnson (JNJ), Gilead Sciences (GILD), Intel (INTC), Alibaba Group (BABA), Intuitive Surgical (ISRG) and Mastercard (MA).

Cooper Companies trades on the New York Stock Exchange (NYSE) under the ticker symbol "COO."

Cooper Companies' stock is owned by a variety of retail and institutional investors. Top institutional shareholders include T. Rowe Price Investment Management Inc. (5.00%), Veritas Asset Management LLP (4.23%), Generation Investment Management LLP (3.32%), Alliancebernstein L.P. (3.18%), Moneta Group Investment Advisors LLC (2.80%) and Victory Capital Management Inc. (2.42%). Insiders that own company stock include Agostino Ricupati, Albert G White III, Brian G Andrews, Daniel G Mcbride, Gary S Petersmeyer, Gerard H Warner III, Holly R Sheffield, Jody S Lindell, Robert D Auerbach and Robert S Weiss.
View institutional ownership trends.

Shares of COO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of COO stock can currently be purchased for approximately $356.59.

Cooper Companies (NYSE:COO) has a market capitalization of $17.64 billion and generates $3.31 billion in revenue each year. The medical device company earns $385.80 million in net income (profit) each year or $7.55 on an earnings per share basis.

The company employs 14,000 workers across the globe.

Cooper Companies' mailing address is 6101 Bollinger Canyon Road Suite 500, San Ramon CA, 94583. The official website for the company is www.coopercos.com. The medical device company can be reached via phone at (925) 460-3600, via email at ir@cooperco.com, or via fax at 925-460-3649.